These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2372513)

  • 21. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA; Verberckmoes R; Michielsen P; Koene RA
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Law CB; Ting SM; Li P; Lai KN
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of recombinant human erythropoietin on haematopoiesis in patients undergoing haemodialysis.
    Swanepoel C; Jacobs P; Byrne MJ; Rayner B; Cassidy MJ; Meyer J
    S Afr Med J; 1996 Aug; 86(8):952-5. PubMed ID: 8823420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
    Sinai-Trieman L; Salusky IB; Fine RN
    J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
    Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
    Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
    Guízar JM; Gutiérrez MJ; Sánchez G; Kornhauser C
    Rev Invest Clin; 1996; 48(3):173-7. PubMed ID: 8966377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
    Macdougall IC; Cavill I; Davies ME; Hutton RD; Coles GA; Williams JD
    Contrib Nephrol; 1989; 76():219-26. PubMed ID: 2582780
    [No Abstract]   [Full Text] [Related]  

  • 31. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin in patients on peritoneal dialysis.
    Bargman J
    Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
    [No Abstract]   [Full Text] [Related]  

  • 34. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.
    Sundal E; Kaeser U
    Nephrol Dial Transplant; 1989; 4(11):979-87. PubMed ID: 2516891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A; Paoletti E; Molinelli G
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoiesis in the anaemia of chronic renal failure: the response to CAPD.
    Coles GA; Cavill I
    Nephrol Dial Transplant; 1986; 1(3):170-4. PubMed ID: 3110671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
    Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J
    Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients.
    Nephron; 1992; 61(4):399-403. PubMed ID: 1501735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous recombinant human erythropoietin treatment of children undergoing peritoneal dialysis.
    Fine RN
    Contrib Nephrol; 1991; 89():186-9. PubMed ID: 1893725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.